PDS Biotechnology Corp. (PDSB)
0.6801
-0.03
(-4.36%)
USD |
NASDAQ |
Feb 12, 16:00
0.6923
+0.01
(+1.79%)
After-Hours: 06:00
PDS Biotechnology Free Cash Flow : -32.28M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Imunon, Inc. | -14.95M |
| Cellectar Biosciences, Inc. | -29.75M |
| PAVmed, Inc. | -3.582M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.916M |
| Cash from Financing (Quarterly) | 0.2412M |
| Free Cash Flow Per Share (Quarterly) | -0.1262 |
| Free Cash Flow to Equity (Quarterly) | -5.346M |
| Free Cash Flow to Firm (Quarterly) | -4.766M |
| Free Cash Flow Yield | -111.0% |